FDA Considers Requiring Sponsors and Investigators to Inform IRBs of Prior IRB Reviews

Summary

The FDA is seeking input on whether to amend its IRB regulations to require sponsors and investigators to disclose prior IRB review decisions, aiming to prevent unfavorable decisions from being ignored and ensure IRBs are aware of other IRBs' conclusions.